NYSE · CIK 0001321732 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Penumbra, Inc
PEN chart by TradingView
PRICE HISTORY
LIVE · NYSEPEN chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $1.4B
- EBITDA
- $0.2B
- FREE CASH FLOW
- $0.2B
- EPS
- $4.52
- GROSS MARGIN
- 67.14%
- ROIC
- —
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
77.8x
-43%60.7x2045.1x
⤢
P / SALES (TTM)
8.3x
-21%5.8x17.1x
⤢
P / BOOK
8.2x
-16%4.8x15.5x
⤢
EV / EBITDA (TTM)
—
⤢
EV / REVENUE (TTM)
—
⤢
FCF YIELD (TTM)
1.73%
+2.5pp-1.25%1.76%
⤢
DIVIDEND YIELD (TTM)
—
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$0.4B
+481%⤢
EBITDA (DERIVED)
$0.0B
+$0.0B⤢
NET INCOME
$0.0B
+192%⤢
EPS (DILUTED)
$0.88
+149%⤢
REVENUE GROWTH YOY
14.90%
-18.4pp-21.68%75.30%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
8.34%
+4.8pp-27.03%19.56%
⤢
RETURN ON CAPITAL
—
⤢
RETURN ON EQUITY (TTM)
10.49%
+3.3pp-3.13%12.45%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN67.93%
OPERATING MARGIN10.52%
NET MARGIN8.92%
FCF MARGIN8.34%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.0B
+1285%⤢
STOCK-BASED COMP
$0.0B
+220%⤢
CAPITAL EXPENDITURE
$0.0B
+300%⤢
SHARES OUTSTANDING
0.04B
+17%⤢
DIVIDEND / SHARE
—
BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$0.2B
+1195%⤢
TOTAL DEBT
—
⤢
DEBT / EBITDA (TTM)
—
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 84.00%INSIDERS 2.89%OTHER / RETAIL 13.11%604 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 10.99% | 4.3M | $1.41B | +4.6% |
| Vanguard Capital Management LLC | 4.30% | 1.7M | $550.1M | NEW |
| Vanguard Portfolio Management LLC | 4.20% | 1.7M | $537.1M | NEW |
| HBK Investments L P | 4.15% | 1.6M | $530.6M | NEW |
| State Street Corporation | 3.01% | 1.2M | $385.0M | +2.5% |
| Millennium Management Llc | 2.79% | 1.1M | $356.5M | +62.0% |
| Geode Capital Management, LLC | 2.02% | 795K | $258.3M | +3.8% |
| Balyasny Asset Management LP | 1.93% | 762K | $247.4M | +370.7% |
| Goldman Sachs Group Inc | 1.83% | 721K | $233.9M | +126.5% |
| UBS Group AG | 1.42% | 560K | $181.9M | +272.6% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.